Clinical Trial Update: MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating mesenchymal stem cells with a CD25 monoclonal antibody and calcineurin inhibitors for steroid-resistant acute graft-versus-host disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CD25 monoclonal antibody (anti-CD25 monoclonal antibody)
• Calcineurin inhibitors
• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Graft-versus-host Disease | Phase 2, Phase 3 | Status: UNKNOWN